日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening

从 DNA 编码化学库筛选中开发小分子非共价冠状病毒 3CL 蛋白酶抑制剂

Hengrui Liu, Arie Zask, Farhad Forouhar, Sho Iketani, Alana Williams, Daniel R Vaz, Dahlya Habashi, Karenna Choi, Samuel J Resnick, Seo Jung Hong, David H Lovett, Tian Bai, Alejandro Chavez, David D Ho, Brent R Stockwell3

A multiplex method for rapidly identifying viral protease inhibitors

一种快速鉴定病毒蛋白酶抑制剂的多重检测方法

Seo Jung Hong # ,Samuel J Resnick # ,Sho Iketani # ,Ji Won Cha ,Benjamin Alexander Albert ,Christopher T Fazekas ,Ching-Wen Chang ,Hengrui Liu ,Shlomi Dagan ,Michael R Abagyan ,Pavla Fajtová ,Bruce Culbertson ,Brooklyn Brace ,Eswar R Reddem ,Farhad Forouhar ,J Fraser Glickman ,James M Balkovec ,Brent R Stockwell ,Lawrence Shapiro ,Anthony J O'Donoghue ,Yosef Sabo ,Joel S Freundlich ,David D Ho ,Alejandro Chavez

MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis

MEF2B C 端突变增强转录活性和稳定性,从而驱动 B 细胞淋巴瘤发生

Chuanjiang Yu ,Qiong Shen ,Antony B Holmes ,Tongwei Mo ,Anna Tosato ,Rajesh Kumar Soni ,Clarissa Corinaldesi ,Sanjay Koul ,Laura Pasqualucci ,Shafinaz Hussein ,Farhad Forouhar ,Riccardo Dalla-Favera ,Katia Basso

MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis

MEF2B C 端突变增强转录活性和稳定性,从而驱动 B 细胞淋巴瘤发生

Chuanjiang Yu,Qiong Shen,Antony B Holmes,Tongwei Mo,Anna Tosato,Rajesh Kumar Soni,Clarissa Corinaldesi,Sanjay Koul,Laura Pasqualucci ,Shafinaz Hussein,Farhad Forouhar,Riccardo Dalla-Favera ,Katia Basso

MpaR-driven expression of an orphan terminal oxidase subunit supports Pseudomonas aeruginosa biofilm respiration and development during cyanogenesis

MpaR 驱动的孤儿末端氧化酶亚基表达支持铜绿假单胞菌生物膜在氰化物生成过程中的呼吸和发育

Marina K Smiley #, Doran C Sekaran #, Farhad Forouhar, Erica Wolin, Marko Jovanovic, Alexa Price-Whelan, Lars E P Dietrich

The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

TINCR 泛素样微蛋白是鳞状细胞癌的肿瘤抑制因子

Lucia Morgado-Palacin #, Jessie A Brown #, Thomas F Martinez, Juana M Garcia-Pedrero, Farhad Forouhar, S Aidan Quinn, Clara Reglero, Joan Vaughan, Yasamin Hajy Heydary, Cynthia Donaldson, Sandra Rodriguez-Perales, Eva Allonca, Rocio Granda-Diaz, Agustin F Fernandez, Mario F Fraga, Arianna L Kim, Jor

Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia

NT5C2 的药物抑制可逆转急性淋巴细胞白血病中 6-MP 耐药性的遗传和非遗传驱动因素

Clara Reglero #, Chelsea L Dieck #, Arie Zask, Farhad Forouhar, Anouchka P Laurent, Wen-Hsuan W Lin, Robert Albero, Hannah I Miller, Cindy Ma, Julie M Gastier-Foster, Mignon L Loh, Liang Tong, Brent R Stockwell, Teresa Palomero, Adolfo A Ferrando

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

开发优化的 SARS-CoV-2 3CL 蛋白酶类药物小分子抑制剂用于治疗 COVID-19

Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednarova, Farhad Forouhar, Brandon Fowler, Seo Jung Hong, Hiroshi Mohri, Manoj S Nair, Yaoxing Huang, Nicholas E S Tay, Sumin Lee, Charles Karan, Samuel J Resnick, Colette Quinn, Wenjing Li, Henry Shion, Xin Xia, Jacob D Daniels, Michelle B

Characterization of a patient-derived variant of GPX4 for precision therapy

对源自患者的GPX4变体进行表征,以用于精准治疗

Hengrui Liu ,Farhad Forouhar ,Tobias Seibt ,Russell Saneto ,Kristen Wigby ,Jennifer Friedman ,Xin Xia ,Mikhail S Shchepinov ,Sanath Kumar Ramesh ,Marcus Conrad ,Brent R Stockwell

Small-molecule allosteric inhibitors of GPX4

GPX4的小分子变构抑制剂

Hengrui Liu ,Farhad Forouhar ,Annie J Lin ,Qian Wang ,Vasiliki Polychronidou ,Rajesh Kumar Soni ,Xin Xia ,Brent R Stockwell